A. Klisic, S. Gluscevic, P. Karakasis, J. Kotur-Stevuljevic, and A. Ninic, “Serum galectin-3 and fibroblast growth factor-23 levels in relation with type 2 diabetes and cardiovascular risk : Galectin-3 and FGF-23 in relation to diabetes and CV risk”, J Med Biochem, vol. 44, no. 1, pp. 85–92, Oct. 2024, doi: 10.5937/jomb0-50471.